Last Updated: July 27, 2026

Patent: 7,279,159


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,279,159
Title:VEGF inhibitor polypeptides
Abstract:Nucleic acid molecules and multimeric proteins capable of binding vascular endothelial growth factor (VEGF). VEGF traps are disclosed which are therapeutically useful for treating VEGF-associated conditions and diseases, and are specifically designed for local administration to specific organs, tissues, and/or cells.
Inventor(s):Thomas J. Daly, James P. Fandl, Nicholas J. Papadopoulos
Assignee: Regeneron Pharmaceuticals Inc
Application Number:US10/880,021
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

United States Patent 7,279,159: Claims, Scope, Expiration, and US Patent Landscape

US Patent 7,279,159 is a litigated US patent with a defined claim set that is central to assessing freedom-to-operate (FTO) around the claimed subject matter. The US landscape analysis turns on (1) the claim construction posture in enforcement and invalidity proceedings, (2) the filing and priority chain that governs term and potential terminal disclaimers, and (3) whether later patents recapture the same technical features via obvious variants or continuation strategy.

Critical point for FTO and licensing: without the asserted independent claims’ exact text (and the prosecution history record for those claims), the enforceable scope cannot be mapped with sufficient specificity to determine whether a competing formulation, manufacturing method, or process step reads on the patent.

Result: No complete, accurate claim-by-claim analysis or landscape mapping can be produced from the information provided.

More… ↓

⤷  Start Trial

Details for Patent 7,279,159

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Sanofi-aventis U.s. Llc ZALTRAP ziv-aflibercept Injection 125418 August 03, 2012 ⤷  Start Trial 2024-06-29
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.